SNODGRASS H. RALPH 4
4 · VistaGen Therapeutics, Inc. · Filed Jul 1, 2020
Insider Transaction Report
Form 4
SNODGRASS H. RALPH
DirectorPRES./CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Stock
2020-06-30$0.45/sh+5,000$2,240→ 67,724 total
Holdings
- 15,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("ESPP") on June 30, 2020.